249 related articles for article (PubMed ID: 31287389)
21. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
[TBL] [Abstract][Full Text] [Related]
22. Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9.
Kim SS; Lee S; Lee HS; Bang S; Han K; Park MS
Radiology; 2022 Jun; 303(3):548-556. PubMed ID: 35258374
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.
Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Yamashita Y; Takamori H; Kanemitsu K; Baba H
Cardiovasc Intervent Radiol; 2007; 30(5):912-21. PubMed ID: 17710478
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.
Tomihara H; Eguchi H; Yamada D; Gotoh K; Kawamoto K; Wada H; Asaoka T; Noda T; Takeda Y; Tanemura M; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):218-226. PubMed ID: 27586014
[TBL] [Abstract][Full Text] [Related]
25. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
26. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?
Yadav AK; Sharma R; Kandasamy D; Pradhan RK; Garg PK; Bhalla AS; Gamanagatti S; Srivastava DN; Sahni P; Upadhyay AD
Pancreatology; 2016; 16(6):979-987. PubMed ID: 27568845
[TBL] [Abstract][Full Text] [Related]
27. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?
Perez RO; Habr-Gama A; São Julião GP; Gama-Rodrigues J; Sousa AH; Campos FG; Imperiale AR; Lynn PB; Proscurshim I; Nahas SC; Ono CR; Buchpiguel CA
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1159-65. PubMed ID: 22580120
[TBL] [Abstract][Full Text] [Related]
28. Computed Tomography Perfusion Analysis of Pancreatic Adenocarcinoma using Deconvolution, Maximum Slope, and Patlak Methods - Evaluation of Diagnostic Accuracy and Interchangeability of Cut-Off Values.
Koell M; Klauss M; Skornitzke S; Mayer P; Fritz F; Stiller W; Grenacher L
Rofo; 2021 Sep; 193(9):1062-1073. PubMed ID: 33772484
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma.
Mokdad AA; Minter RM; Yopp AC; Porembka MR; Wang SC; Zhu H; Augustine MM; Mansour JC; Choti MA; Polanco PM
J Natl Compr Canc Netw; 2018 Dec; 16(12):1468-1475. PubMed ID: 30545994
[No Abstract] [Full Text] [Related]
30. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H
Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151
[TBL] [Abstract][Full Text] [Related]
31. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
Wang ZJ; Behr S; Consunji MV; Yeh BM; Ohliger MA; Gao K; Ko AH; Cinar P; Tempero MA; Collisson EA
AJR Am J Roentgenol; 2018 Nov; 211(5):1010-1019. PubMed ID: 30063366
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma.
O'Malley RB; Soloff EV; Coveler AL; Cox DH; Desai N; Busey JM; Valentin GM; Wang CL
Abdom Radiol (NY); 2021 May; 46(5):1992-2002. PubMed ID: 33079256
[TBL] [Abstract][Full Text] [Related]
33. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
34. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
35. Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation.
Bettini N; Moutardier V; Turrini O; Bories E; Monges G; Giovannini M; Delpero JR
Gastroenterol Clin Biol; 2005; 29(6-7):659-63. PubMed ID: 16141999
[TBL] [Abstract][Full Text] [Related]
36. Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study.
Djuric-Stefanovic A; Saranovic D; Micev M; Stankovic V; Plesinac-Karapandzic V; Pesko P; Stojakov D; Sabljak P; Bjelovic M
J BUON; 2014; 19(1):237-44. PubMed ID: 24659670
[TBL] [Abstract][Full Text] [Related]
37. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study.
Kim H; Morgan DE; Schexnailder P; Navari RM; Williams GR; Bart Rose J; Li Y; Paluri R
Invest Radiol; 2019 Jan; 54(1):16-22. PubMed ID: 30138218
[TBL] [Abstract][Full Text] [Related]
38. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
[TBL] [Abstract][Full Text] [Related]
39. Dual-energy perfusion-CT of pancreatic adenocarcinoma.
Klauss M; Stiller W; Pahn G; Fritz F; Kieser M; Werner J; Kauczor HU; Grenacher L
Eur J Radiol; 2013 Feb; 82(2):208-14. PubMed ID: 23062281
[TBL] [Abstract][Full Text] [Related]
40. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
Fraioli F; Anzidei M; Serra G; Liberali S; Fiorelli A; Zaccagna F; Longo F; Anile M; Catalano C
Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
